Would Federal Legalization Affect State Laws?
Explore how federal legalization of cannabis could impact existing state laws.
Cannabis sits in Schedule I of the Controlled Substances Act. The Drug Enforcement Administration published a proposed rule on May 21, 2024 to move it to Schedule III. That rule is a proposal. No final order has taken effect. Placement in Schedule III would change federal tax and registration rules. It would not legalize cannabis, and it would not create a federal retail market.
Would Federal Legalization Affect State Laws?
How the process reached this point
On October 6, 2022, the White House directed the Department of Health and Human Services and the Attorney General to review how cannabis is scheduled. HHS finished a scientific review and sent a recommendation to DEA on August 29, 2023. HHS concluded that cannabis has accepted medical use in the United States and recommended placement in Schedule III.
DEA then drafted its own rule. The proposed rule appeared in the Federal Register on May 21, 2024. The comment period closed in July 2024. Several parties asked for a hearing. DEA granted a hearing before an administrative law judge, and testimony began in January 2025. This page reflects the record through those hearings. Later actions may have occurred. The Federal Register docket holds the current stage.
Federal Marijuana Legalization: Current Status and How to Track It
Steps that remain
- Administrative law judge hearings, with testimony from proponents, opponents, and DEA.
- The judge's recommendation to the DEA Administrator.
- The Administrator's final order, published in the Federal Register.
- Possible appeals in federal court under 21 U.S.C. 877.
Each step can take months. A final rule date is not set, and no published schedule exists.
Cannabis Federal vs State Conflict: Understanding the Differences
What changes under Schedule III
- Section 280E of the tax code stops applying. Licensed operators could deduct ordinary business expenses.
- Manufacturers, distributors, and dispensaries that handle cannabis would need DEA registration.
- FDA rules for medical use would apply to the federal framework.
- Research registration requirements ease.
What does not change
- State license rules. A state permit stays the operating requirement.
- State retail sales to adults 21 and older. Rescheduling does not authorize them under federal law.
- Possession. Cannabis stays a controlled substance. Possession without a DEA registration or another federal defense stays a federal offense, though enforcement against state-compliant activity is rare.
- Hemp. Hemp under 0.3% delta-9 THC is governed by the 2018 farm bill, a separate statute.
- Shipping. Moving cannabis across state lines stays a federal offense.
What to check
The Federal Register docket carries the filed documents. The DEA Diversion Control Division posts hearing notices. Court dockets in the circuit courts show appeals. Claims about a "final rule" circulate before publication. The filed notice is the source that counts.
Effect on buying in a legal state
Rescheduling does not change what a state-licensed store may sell or who may enter. It does not create federal product standards, testing rules, or label rules for adult-use products. Those stay with the state. A buyer in a legal state sees the same rules after a final order as before it, unless the state legislature acts.